Soleus Capital Special Opportunities Fund, L.P. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 5:27 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,525,457 8.010% |
50,799 (+1.46%) |
Filing |
| 2021-02-12 4:01 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,474,658 9.990% |
630,471 (+22.17%) |
Filing |
| 2020-08-03 12:56 pm Purchase |
2020-07-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 2,844,187 9.990% |
721,214 (+33.97%) |
Filing |